$SERA
SERA PROGNOSTICS, INC. Stock $sera

$sera Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000153496922000068 Filed on May 10, 2022

Income Statement

Concept	2022 Q1	2021 Q1
Revenue	$38.00K	$13.00K
YoY Change	192.31%	62.5%
Cost Of Revenue	$20.00K	$5.000K
YoY Change	300.0%	66.67%
Gross Profit	$18.00K	$8.000K
YoY Change	125.0%	60.0%
Gross Profit Margin	47.37%	61.54%
Selling, General & Admin	$8.996M	$3.637M
YoY Change	147.35%	61.86%
% of Gross Profit	49977.78%	45462.5%
Research & Development	$3.322M	$2.396M
YoY Change	38.65%	16.88%
% of Gross Profit	18455.56%	29950.0%
Depreciation & Amortization	$200.0K	$200.0K
YoY Change	0.0%	-11.89%
% of Gross Profit	1111.11%	2500.0%
Operating Expenses	$12.34M	$6.038M
YoY Change	104.34%	40.52%
Operating Profit	-$12.30M	-$6.025M
YoY Change	104.15%	40.38%
Interest Expense	$4.000K	$307.0K
YoY Change	-98.7%	-175.06%
% of Operating Profit
Other Income/Expense, Net	$96.00K	-$27.00K
YoY Change	-455.56%	-640.0%
Pretax Income	-$12.21M	-$6.359M
YoY Change	91.98%	35.41%
Income Tax
% Of Pretax Income
Net Earnings	-$12.21M	-$6.359M
YoY Change	91.98%	35.41%
Net Earnings / Revenue	-32126.32%	-48915.38%
Basic Earnings Per Share	-$0.40	-$3.55
Diluted Earnings Per Share	-$0.40	-$3.55
COMMON SHARES
Basic Shares Outstanding	30.80M shares	1.792M shares
Diluted Shares Outstanding	30.80M shares	1.792M shares

Balance Sheet

Concept	2022 Q1	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$107.5M	$60.02M
YoY Change	79.2%
Cash & Equivalents	$64.10M	$60.02M
Short-Term Investments	$43.47M
Other Short-Term Assets	$1.875M	$421.0K
YoY Change	345.37%
Inventory
Prepaid Expenses
Receivables	$39.00K	$8.000K
Other Receivables	$9.000K	$0.00
Total Short-Term Assets	$109.5M	$60.45M
YoY Change	81.11%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.913M	$826.0K
YoY Change	252.66%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$22.34M
YoY Change
Other Assets	$487.0K	$1.473M
YoY Change	-66.94%
Total Long-Term Assets	$25.40M	$2.299M
YoY Change	1004.61%
TOTAL ASSETS
Total Short-Term Assets	$109.5M	$60.45M
Total Long-Term Assets	$25.40M	$2.299M
Total Assets	$134.9M	$62.74M
YoY Change	114.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$945.0K	$829.0K
YoY Change	13.99%
Accrued Expenses	$2.007M	$1.742M
YoY Change	15.21%
Deferred Revenue	$3.112M
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$351.0K	$772.0K
YoY Change	-54.53%
Total Short-Term Liabilities	$6.944M	$3.736M
YoY Change	85.87%
LONG-TERM LIABILITIES
Long-Term Debt	$718.0K	$457.0K
YoY Change	57.11%
Other Long-Term Liabilities		$594.9K
YoY Change
Total Long-Term Liabilities	$718.0K	$1.052M
YoY Change	-31.74%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.944M	$3.736M
Total Long-Term Liabilities	$718.0K	$1.052M
Total Liabilities	$7.662M	$4.788M
YoY Change	60.03%
SHAREHOLDERS EQUITY
Retained Earnings	-$178.7M
YoY Change
Common Stock	$3.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$127.2M	-$130.4M
YoY Change
Total Liabilities & Shareholders Equity	$134.9M	$62.74M
YoY Change	114.94%

Cashflow Statement

Concept	2022 Q1	2021 Q1
OPERATING ACTIVITIES
Net Income	-$12.21M	-$6.359M
YoY Change	91.98%	35.41%
Depreciation, Depletion And Amortization	$200.0K	$200.0K
YoY Change	0.0%	-11.89%
Cash From Operating Activities	-$9.557M	-$6.950M
YoY Change	37.51%	50.6%
INVESTING ACTIVITIES
Capital Expenditures	$7.000K	$41.00K
YoY Change	-82.93%	-612.5%
Acquisitions
YoY Change
Other Investing Activities	$14.64M
YoY Change
Cash From Investing Activities	$14.63M	-$41.00K
YoY Change	-35792.68%	412.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$71.00K	$53.47M
YoY Change	-99.87%	401.3%
NET CHANGE
Cash From Operating Activities	-$9.557M	-$6.950M
Cash From Investing Activities	$14.63M	-$41.00K
Cash From Financing Activities	$71.00K	$53.47M
Net Change In Cash	$5.148M	$46.48M
YoY Change	-88.92%	669.08%
FREE CASH FLOW
Cash From Operating Activities	-$9.557M	-$6.950M
Capital Expenditures	$7.000K	$41.00K
Free Cash Flow	-$9.564M	-$6.991M
YoY Change	36.8%	51.75%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001534969
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	SERA PROGNOSTICS, INC.
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2021Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.481000
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2021Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesAndOtherLiabilities
CY2022Q1	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesAndOtherLiabilities
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	001-40606
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-1911522
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	2749 East Parleys Way
CY2022Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 200
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Salt Lake City
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	UT
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	84109
CY2022Q1	dei	City Area Code CityAreaCode	801
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	990-0520
CY2022Q1	dei	Security12b Title Security12bTitle	Class A Common Stock, $0.0001 par value per share
CY2022Q1	dei	Trading Symbol TradingSymbol	SERA
CY2022Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2021Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	34848000	USD
CY2022Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	64080000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	58932000	USD
CY2022Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	43467000	USD
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	46183000	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	39000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	27000	USD
CY2022Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	9000	USD
CY2021Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	3116000	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1875000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1993000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	109470000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	110251000	USD
CY2022Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	2571000	USD
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	1773000	USD
CY2022Q1	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	22337000	USD
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	487000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	157000	USD
CY2022Q1	us-gaap	Assets Assets	134865000	USD
CY2021Q4	us-gaap	Assets Assets	147029000	USD
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	945000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1197000	USD
CY2022Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	2536000	USD
CY2021Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	3885000	USD
CY2022Q1	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	0	USD
CY2021Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	139000	USD
CY2022Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	351000	USD
CY2021Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	74000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3112000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3116000	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	6944000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8411000	USD
CY2022Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	718000	USD
CY2021Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	54000	USD
CY2022Q1	us-gaap	Liabilities Liabilities	7662000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	8465000	USD
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	3000	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	3000	USD
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	306532000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	305212000	USD
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-656000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-183000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-178676000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-166468000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	127203000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	138564000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	134865000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	147029000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	38000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13000	USD
CY2022Q1	sera	Cost Of Revenue Excluding Selling Marketing General And Administrative Expense CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense	20000	USD
CY2021Q1	sera	Cost Of Revenue Excluding Selling Marketing General And Administrative Expense CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense	5000	USD
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3322000	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2396000	USD
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4458000	USD
CY2021Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1350000	USD
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4538000	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2287000	USD
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	12338000	USD
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	6038000	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-12300000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-6025000	USD
CY2022Q1	us-gaap	Interest Expense InterestExpense	4000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	307000	USD
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	96000	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-27000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-12208000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-6359000	USD
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.40
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.40
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.55
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.55
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30801579	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30801579	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1791841	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1791841	shares
CY2022Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-473000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	0	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-12208000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-6359000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-473000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12681000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6359000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	138564000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	98000	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1222000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-473000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-12208000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	127203000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-125570000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	1071000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	229000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	239000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-6359000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-130390000	USD
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	165000	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	201000	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1222000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	239000	USD
CY2022Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	2000	USD
CY2021Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	168000	USD
CY2022Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-36000	USD
CY2021Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-19000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	12000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-3116000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	0	USD
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-320000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	223000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-252000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	339000	USD
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-1942000	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-1297000	USD
CY2022Q1	sera	Increase Decrease In Deferred Rent IncreaseDecreaseInDeferredRent	0	USD
CY2021Q1	sera	Increase Decrease In Deferred Rent IncreaseDecreaseInDeferredRent	-31000	USD
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-4000	USD
CY2021Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	0	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9557000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6950000	USD
CY2022Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	6614000	USD
CY2021Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	0	USD
CY2022Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	21252000	USD
CY2021Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	USD
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	41000	USD
CY2022Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	3000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	14634000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-41000	USD
CY2022Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	1071000	USD
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	89000	USD
CY2021Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	229000	USD
CY2022Q1	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	USD
CY2021Q1	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	4494000	USD
CY2022Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	0	USD
CY2021Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	3100000	USD
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	18000	USD
CY2021Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	17000	USD
CY2022Q1	sera	Payments Of Deferred Stock Issuance Costs PaymentsOfDeferredStockIssuanceCosts	0	USD
CY2021Q1	sera	Payments Of Deferred Stock Issuance Costs PaymentsOfDeferredStockIssuanceCosts	630000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	71000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	53474000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	5148000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	46483000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	58932000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13533000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	64080000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	60016000	USD
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	2000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	1277000	USD
CY2022Q1	sera	Purchases Of Property And Equipment Included In Accounts Payable And Accrued Liabilities PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities	0	USD
CY2021Q1	sera	Purchases Of Property And Equipment Included In Accounts Payable And Accrued Liabilities PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities	21000	USD
CY2022Q1	sera	Senior Convertible Preferred Stock Offering Costs Included In Accounts Payable And Accrued Liabilities SeniorConvertiblePreferredStockOfferingCostsIncludedInAccountsPayableAndAccruedLiabilities	0	USD
CY2021Q1	sera	Senior Convertible Preferred Stock Offering Costs Included In Accounts Payable And Accrued Liabilities SeniorConvertiblePreferredStockOfferingCostsIncludedInAccountsPayableAndAccruedLiabilities	82000	USD
CY2022Q1	sera	Prepaid And Deferred Offering Costs Reclassified To Senior Convertible Preferred Stock PrepaidAndDeferredOfferingCostsReclassifiedToSeniorConvertiblePreferredStock	0	USD
CY2021Q1	sera	Prepaid And Deferred Offering Costs Reclassified To Senior Convertible Preferred Stock PrepaidAndDeferredOfferingCostsReclassifiedToSeniorConvertiblePreferredStock	26000	USD
CY2022Q1	sera	Deferred Offering Costs Incurred But Not Yet Paid DeferredOfferingCostsIncurredButNotYetPaid	0	USD
CY2021Q1	sera	Deferred Offering Costs Incurred But Not Yet Paid DeferredOfferingCostsIncurredButNotYetPaid	771000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-178700000	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	64100000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	65800000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	0	USD
CY2022Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the amounts reported in the condensed financial statements and accompanying notes. The Company evaluates these estimates on an ongoing basis. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ materially from those estimates.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic and the evolving actions of governments, private sector participants and the public in an effort to contain the spread of the COVID-19 virus and address its impacts have intensified and have had significant direct and indirect effects on businesses and commerce. The extent to which the COVID-19 pandemic may impact the </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company’s business, financial condition, cash flows, and results of operations, in particular, will depend on future developments that are highly uncertain, many of which are outside the Company’s control. Such developments include the availability and effectiveness of actions taken to contain or treat COVID-19, the ultimate geographic spread and duration of the pandemic, the extent and duration of a resurgence of the COVID-19 virus and variant strains thereof, new information concerning the severity of the COVID-19 virus, the effectiveness and intensity of measures to contain the COVID-19 virus and the economic impact of the pandemic and the reactions to it. Such developments, among others, depending on their nature, duration, and intensity, could have a significant adverse effect on the Company’s business, financial condition, cash flows, and results of operations.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no significant estimates contained in the preparation of the Company’s condensed financial statements or impacts to the Company’s condensed financial statements for the three months ended March 31, 2022 that were a direct result of the COVID-19 pandemic. The Company is not aware of any specific event or circumstance that would require an update to its estimates, judgments and assumptions or a revision of the carrying value of the Company’s assets or liabilities as of the date of the condensed financial statements.</span></div>
CY2022Q1	sera	Cash And Cash Equivalents Debt Securities Available For Sale Amortized Cost CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost	130540000	USD
CY2022Q1	sera	Cash And Cash Equivalents Debt Securities Available For Sale Accumulated Gross Unrealized Gain Before Tax CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax	2000	USD
CY2022Q1	sera	Cash And Cash Equivalents Debt Securities Available For Sale Accumulated Gross Unrealized Loss Before Tax CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax	658000	USD
CY2022Q1	sera	Cash And Cash Equivalents Debt Securities Available For Sale Fair Value CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue	129884000	USD
CY2021Q4	sera	Cash And Cash Equivalents Debt Securities Available For Sale Amortized Cost CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost	140146000	USD
CY2021Q4	sera	Cash And Cash Equivalents Debt Securities Available For Sale Accumulated Gross Unrealized Gain Before Tax CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2021Q4	sera	Cash And Cash Equivalents Debt Securities Available For Sale Accumulated Gross Unrealized Loss Before Tax CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax	183000	USD
CY2021Q4	sera	Cash And Cash Equivalents Debt Securities Available For Sale Fair Value CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue	139963000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	0	USD
CY2021Q4	us-gaap	Other Than Temporary Impairment Credit Losses Recognized In Earnings Credit Losses On Debt Securities Held OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld	0	USD
CY2022Q1	us-gaap	Other Than Temporary Impairment Credit Losses Recognized In Earnings Credit Losses On Debt Securities Held OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld	0	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	43696000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	43467000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	22759000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	22337000	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	66455000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	65804000	USD
CY2022Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	8703000	USD
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	7740000	USD
CY2022Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	6132000	USD
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	5967000	USD
CY2022Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	2571000	USD
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	1773000	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	200000	USD
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	200000	USD
CY2022Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	954000	USD
CY2021Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	2498000	USD
CY2022Q1	us-gaap	Accrued Vacation Current AccruedVacationCurrent	607000	USD
CY2021Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	460000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	446000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	USD
CY2022Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	529000	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	927000	USD
CY2022Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	2536000	USD
CY2021Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	3885000	USD
CY2022Q1	sera	Common Stock Conversion Ratio CommonStockConversionRatio	1
CY2022Q1	us-gaap	Interest Income Other InterestIncomeOther	78000	USD
CY2021Q1	us-gaap	Interest Income Other InterestIncomeOther	2000	USD
CY2022Q1	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	0	USD
CY2021Q1	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	-10000	USD
CY2022Q1	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	18000	USD
CY2021Q1	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	-19000	USD
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	96000	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-27000	USD
CY2022Q1	sera	Number Of Common Stock Classes Authorized NumberOfCommonStockClassesAuthorized	2	common_stock_class
CY2021Q4	sera	Deferred Offering Costs Non Current DeferredOfferingCostsNonCurrent	3100000	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6287126	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.36
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y9M18D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	20095000	USD
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1918637	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	4.30
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	65381	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	6.94
CY2022Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	123467	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.80
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8016915	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.38
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y2M12D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	7047000	USD
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	7488330	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	4.30
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P8Y1M6D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	6931000	USD
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	2967940	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	2.51
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P6Y4M24D
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	5135000	USD
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1222000	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	239000	USD
CY2022Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	15300000	USD
CY2022Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y1M6D
CY2022Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2788484	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2788484	shares
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	0	USD
CY2022Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	0	USD
CY2022Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	0	USD
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	0	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	342000	USD
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	1188000	USD
CY2022Q1	sera	Right Of Use Asset Total RightOfUseAssetTotal	1530000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	446000	USD
CY2022Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	351000	USD
CY2022Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	718000	USD
CY2022Q1	sera	Lease Liabilities Total LeaseLiabilitiesTotal	1515000	USD
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	16000	USD
CY2022Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	4000	USD
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	116000	USD
CY2022Q1	us-gaap	Lease Cost LeaseCost	136000	USD
CY2022Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	2000	USD
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	18000	USD
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	958000	USD
CY2022Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y10M24D
CY2022Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.063
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	151000	USD
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	453000	USD
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y9M18D
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.045
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	453000	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	295000	USD
CY2022Q1	sera	Lease Liability To Be Paid Remainder Of Fiscal Year LeaseLiabilityToBePaidRemainderOfFiscalYear	748000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	0	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	407000	USD
CY2022Q1	sera	Lease Liability To Be Paid Year One LeaseLiabilityToBePaidYearOne	407000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	0	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	351000	USD
CY2022Q1	sera	Lease Liability To Be Paid Year Two LeaseLiabilityToBePaidYearTwo	351000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	0	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	117000	USD
CY2022Q1	sera	Lease Liability To Be Paid Year Three LeaseLiabilityToBePaidYearThree	117000	USD
CY2022Q1	sera	Lessee Operating Lease Liability To Be Paid Year Four And Thereafter LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter	0	USD
CY2022Q1	sera	Finance Lease Liability To Be Paid Year Four And Thereafter FinanceLeaseLiabilityToBePaidYearFourAndThereafter	0	USD
CY2022Q1	sera	Lease Liability To Be Paid Year Four And Thereafter LeaseLiabilityToBePaidYearFourAndThereafter	0	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	453000	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	1170000	USD
CY2022Q1	sera	Lease Liability Payment Due LeaseLiabilityPaymentDue	1623000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	7000	USD
CY2022Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	101000	USD
CY2022Q1	sera	Lease Liability Undiscounted Excess Amount LeaseLiabilityUndiscountedExcessAmount	108000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	446000	USD
CY2022Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	1069000	USD
CY2022Q1	sera	Lease Liabilities Total LeaseLiabilitiesTotal	1515000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	446000	USD
CY2022Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	351000	USD
CY2022Q1	sera	Lease Liability Current LeaseLiabilityCurrent	797000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	USD
CY2022Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	718000	USD
CY2022Q1	sera	Lease Liability Noncurrent LeaseLiabilityNoncurrent	718000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2022Q1	sera	Indemnification Liability IndemnificationLiability	0	USD
CY2021Q4	sera	Indemnification Liability IndemnificationLiability	0	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-6359000	USD
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1791841	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1791841	shares
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.55
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.55
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10805399	shares
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	28276952	shares

Files In Submission

Name	View Source	Status
0001534969-22-000068-index-headers.html	Edgar Link	pending
0001534969-22-000068-index.html	Edgar Link	pending
0001534969-22-000068.txt	Edgar Link	pending
0001534969-22-000068-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sera-20220331.htm	Edgar Link	pending
sera-20220331.xsd	Edgar Link	pending
sera-20220331x10qxex311.htm	Edgar Link	pending
sera-20220331x10qxex312.htm	Edgar Link	pending
sera-20220331x10qxex321.htm	Edgar Link	pending
sera-20220331_cal.xml	Edgar Link	unprocessable
sera-20220331_def.xml	Edgar Link	unprocessable
sera-20220331_htm.xml	Edgar Link	completed
sera-20220331_lab.xml	Edgar Link	unprocessable
sera-20220331_pre.xml	Edgar Link	unprocessable
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SERA
SERA PROGNOSTICS, INC. Stock $sera

2022 Q1 Form 10-Q Financial Statement

#000153496922000068 Filed on May 10, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SERA SERA PROGNOSTICS, INC. Stock $sera

2022 Q1 Form 10-Q Financial Statement

#000153496922000068 Filed on May 10, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SERA
SERA PROGNOSTICS, INC. Stock $sera